Top Healthcare companies in United States by Return on Assets (ROA)

This ranking features the top 443 Healthcare companies in United States ranked by Return on Assets (ROA), averaging a Return on Assets (ROA) of -20.27%, for February 04, 2025.

United States

Healthcare

#	Name	Return on Assets (ROA)	Reported Date	Stock Price	Change	Country
1	Agios Pharmaceuticals, Inc. 1 AGIO	61.98%	Sept. 30, 2024	USD 33.62	-2.24%	United States
2	MiMedx Group, Inc. 2 MDXG	41.79%	Sept. 30, 2024	USD 8.54	-1.84%	United States
3	Edwards Lifesciences Corporation 3 EW	39.45%	Sept. 30, 2024	USD 71.38	-1.48%	United States
4	SIGA Technologies, Inc. 4 SIGA	38.70%	Sept. 30, 2024	USD 5.78	-3.34%	United States
5	Protagonist Therapeutics, Inc. 5 PTGX	30.98%	Sept. 30, 2024	USD 37.20	-1.59%	United States
6	Lantheus Holdings, Inc. 6 LNTH	22.89%	Sept. 30, 2024	USD 89.54	-3.21%	United States
7	Catalyst Pharmaceuticals, Inc. 7 CPRX	21.99%	Sept. 30, 2024	USD 22.62	0.27%	United States
8	National Research Corporation 8 NRC	21.92%	Sept. 30, 2024	USD 16.36	-1.86%	United States
9	Halozyme Therapeutics, Inc. 9 HALO	20.49%	Sept. 30, 2024	USD 56.28	-0.64%	United States
10	IRadimed Corporation 10 IRMD	20.45%	Sept. 30, 2024	USD 59.35	0.24%	United States
11	Corcept Therapeutics Incorporated 11 CORT	20.36%	Sept. 30, 2024	USD 66.55	-0.55%	United States
12	Medpace Holdings, Inc. 12 MEDP	19.61%	Sept. 30, 2024	USD 343.38	-1.65%	United States
13	ADMA Biologics, Inc. 13 ADMA	18.83%	Sept. 30, 2024	USD 16.47	1.98%	United States
14	Semler Scientific, Inc. 14 SMLR	18.78%	Sept. 30, 2024	USD 50.46	-2.89%	United States
15	Bath & Body Works, Inc. 15 BBWI	17.93%	Nov. 2, 2024	USD 38.00	1.04%	United States
16	ResMed Inc. 16 RMD	17.81%	Dec. 31, 2024	USD 240.55	1.85%	United States
17	CorVel Corporation 17 CRVL	17.74%	Dec. 31, 2023	USD 115.97	0.10%	United States
18	Doximity, Inc. 18 DOCS	16.30%	Sept. 30, 2024	USD 59.10	NA	United States
19	Exelixis, Inc. 19 EXEL	16.27%	Sept. 27, 2024	USD 32.88	-0.81%	United States
20	United Therapeutics Corporation 20 UTHR	16.15%	Sept. 30, 2024	USD 354.58	0.97%	United States
21	Insulet Corporation 21 PODD	15.14%	Sept. 30, 2024	USD 278.90	0.19%	United States
22	ACADIA Pharmaceuticals Inc. 22 ACAD	14.71%	Sept. 30, 2024	USD 18.51	-0.80%	United States
23	Harmony Biosciences Holdings, Inc. 23 HRMY	14.24%	Sept. 30, 2024	USD 38.70	-0.18%	United States
24	Waters Corporation 24 WAT	13.76%	Sept. 28, 2024	USD 411.19	-1.03%	United States
25	West Pharmaceutical Services, Inc. 25 WST	13.69%	Sept. 30, 2024	USD 337.03	-1.32%	United States
26	Intuitive Surgical, Inc. 26 ISRG	13.66%	Sept. 30, 2024	USD 578.55	1.17%	United States
27	Regeneron Pharmaceuticals, Inc. 27 REGN	13.21%	Sept. 30, 2024	USD 666.85	-0.91%	United States
28	RCM Technologies, Inc. 28 RCMT	12.97%	Sept. 28, 2024	USD 19.43	-0.51%	United States
29	Pro-Dex, Inc. 29 PDEX	12.30%	Dec. 31, 2024	USD 35.30	-7.03%	United States
30	Eli Lilly and Company 30 LLY	12.16%	Sept. 30, 2024	USD 810.43	-0.08%	United States
31	Cognizant Technology Solutions Corporation 31 CTSH	11.91%	Sept. 30, 2024	USD 82.90	0.35%	United States
32	Agilent Technologies, Inc. 32 A	11.55%	Oct. 31, 2024	USD 148.63	-1.91%	United States
33	Utah Medical Products, Inc. 33 UTMD	11.50%	Sept. 30, 2024	USD 59.92	-2.14%	United States
34	LeMaitre Vascular, Inc. 34 LMAT	11.47%	Sept. 30, 2024	USD 95.43	-1.55%	United States
35	Neurocrine Biosciences, Inc. 35 NBIX	11.38%	Sept. 30, 2024	USD 150.10	-1.13%	United States
36	Merck & Co., Inc. 36 MRK	10.98%	Sept. 30, 2024	USD 99.79	0.98%	United States
37	Tenet Healthcare Corporation 37 THC	10.79%	Sept. 30, 2024	USD 144.64	2.66%	United States
38	Puma Biotechnology, Inc. 38 PBYI	10.68%	Sept. 30, 2024	USD 2.79	-3.46%	United States
39	Organon & Co. 39 OGN	10.65%	Sept. 30, 2024	USD 14.91	-4.18%	United States
40	DexCom, Inc. 40 DXCM	10.51%	Sept. 30, 2024	USD 87.05	0.25%	United States
41	Entrada Therapeutics, Inc. 41 TRDA	10.38%	Sept. 30, 2024	USD 13.33	-0.82%	United States
42	HCA Healthcare, Inc. 42 HCA	10.31%	Sept. 30, 2024	USD 334.30	1.33%	United States
43	Amphastar Pharmaceuticals, Inc. 43 AMPH	10.30%	Sept. 30, 2024	USD 33.39	-4.24%	United States
44	National HealthCare Corporation 44 NHC	8.98%	Sept. 30, 2024	USD 101.01	-1.62%	United States
45	Hologic, Inc. 45 HOLX	8.96%	Sept. 28, 2024	USD 71.72	-0.58%	United States
46	Stryker Corporation 46 SYK	8.85%	Sept. 30, 2024	USD 391.14	-0.04%	United States
47	Johnson & Johnson 47 JNJ	8.40%	Sept. 29, 2024	USD 151.87	-0.18%	United States
48	Abbott Laboratories 48 ABT	7.87%	Sept. 30, 2024	USD 128.45	0.41%	United States
49	Walmart Inc. 49 WMT	7.68%	Oct. 31, 2024	USD 99.54	1.41%	United States
50	Maximus, Inc. 50 MMS	7.58%	Sept. 30, 2024	USD 75.79	0.66%	United States

1 2 3 4 … 9

Frequently Asked Questions

Which Healthcare company in United States has the highest Return on Assets (ROA) ?

The Healthcare company in United States with the highest Return on Assets (ROA) is Agios Pharmaceuticals, Inc. (NasdaqGS: AGIO) at 61.98%.
Which Healthcare company in United States has the lowest Return on Assets (ROA) ?

The Healthcare company in United States with the lowest Return on Assets (ROA) is TriSalus Life Sciences, Inc. (NasdaqGM: TLSI) at -198.34%.

What are the top 10 Healthcare companies in United States by Return on Assets (ROA) ?

The top 10 Healthcare companies in United States by Return on Assets (ROA) are Agios Pharmaceuticals, Inc., MiMedx Group, Inc., Edwards Lifesciences Corporation, SIGA Technologies, Inc., Protagonist Therapeutics, Inc., Lantheus Holdings, Inc., Catalyst Pharmaceuticals, Inc., National Research Corporation, Halozyme Therapeutics, Inc. and IRadimed Corporation.
What are the bottom 10 Healthcare companies in United States by Return on Assets (ROA) ?

The bottom 10 Healthcare companies in United States by Return on Assets (ROA) are TriSalus Life Sciences, Inc., Galectin Therapeutics Inc., Biohaven Pharmaceutical Holding Company Ltd., Elicio Therapeutics, Inc., Gain Therapeutics, Inc., Cidara Therapeutics, Inc., Immunome, Inc., Synlogic, Inc., Polarean Imaging plc and Humacyte, Inc..

Frequently Asked Questions

Don’t Miss A Beat